- Home
- TOUR vs TLPH Comparison
TOUR vs TLPH Comparison
Compare TOUR & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TOUR | TLPH |
|---|---|---|
| Founded | 2006 | 2005 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.2M | 54.5M |
| IPO Year | 2014 | 2010 |
Fundamental Metrics
Financial Performance| Metric | TOUR | TLPH |
|---|---|---|
| Price | $4.78 | $0.87 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $3.13 |
| AVG Volume (30 Days) | 3.5K | ★ 77.5K |
| Earning Date | 12-04-2026 | 11-12-2026 |
| Dividend Yield | ★ 25.52% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,151,000.00 |
| Revenue This Year | $5.00 | N/A |
| Revenue Next Year | $3.00 | N/A |
| P/E Ratio | $87.34 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.56 | $0.69 |
| 52 Week High | $7.79 | $1.57 |
Technical Indicators
Market Signals| Indicator | TOUR | TLPH |
|---|---|---|
| Relative Strength Index (RSI) | 39.42 | 27.98 |
| Support Level | $4.63 | $0.74 |
| Resistance Level | $5.29 | $0.89 |
| Average True Range (ATR) | 0.05 | 0.07 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 6.19 | 25.63 |
Price Performance
Historical ComparisonAbout TOUR Tuniu Corporation
Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. The company offers a large selection of packaged tours, including organized tours and self-guided tours, and travel-related services for leisure travellers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. The company derives almost all of its revenue from PRC.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.